X

Trial Profile

Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer

Status: Discontinued

Phase of Trial: Phase III

Latest Information Update: 06 Feb 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Letrozole (Primary) ; Anastrozole
Indications Early breast cancer
Focus Registrational; Therapeutic Use
Acronyms FACE
Sponsors Novartis

Most Recent Events

23 Jan 2017 Final results published in the Journal of Clinical Oncology.
12 Dec 2015 Results presented at the 38th Annual San Antonio Breast Cancer Symposium
12 Dec 2015 Primary endpoint "Disease-free survival rate" has not been met, as per the results presented at the 38th Annual San Antonio Breast Cancer Symposium.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com